November 28, 2025Clinical EpileptologyOpen Access

Neonatal developmental and epileptic encephalopathies. English version

View Full Paper

Ask AI

Bookmark

Neonatal epileptic encephalopathies feature treatment-resistant seizures, often due to genetic factors.
Up to 80% of cases can be identified with expanded diagnostic tools, improving long-term outcomes.
Assessment of early infantile DEEs utilizes advanced methods to enhance treatment interventions.
Precision medicine advances allow targeting of specific genetic variants like KCNQ2 and SCN2A.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Analysis reveals genetic variants contribute to drug-resistant seizures in neonates, highlighting the importance of precision medicine and diagnostic tools.

Cite This Study

Datta et al. (2025) studied this question.

synapsesocial.com/papers/6928f113a65b730b9ea79d6d https://doi.org/10.1007/s10309-025-00805-w

View Full Paper

Ask AI

Bookmark

Implication

Analysis reveals genetic variants contribute to drug-resistant seizures in neonates, highlighting the importance of precision medicine and diagnostic tools.

Neonatal developmental and epileptic encephalopathies. English version

Key Points

Discussion

Implication

Cite This Study

Neonatal developmental and epileptic encephalopathies. English version

Key Points

Discussion

Implication

Cite This Study

Keep reading

Keep reading